TRUPCR® HCV Viral Load Kit
Hepatitis C is a liver disease caused by hepatitis C virus (HCV). HCV infection is generally asymptomatic during the acute phase and about 85% of them become chronically infected. However, most instances of acute infection are clinically undetectable. The primary objective of anti-HCV treatment is the Sustained Virologic Response (SVR), defined as undetectable HCV RNA by a sensitive test 12 or 24 weeks after the end of treatment.
The TRUPCR® HCV KIT is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the detection of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals. The TRUPCR® HCV KIT assay is intended for use as an aid in the management of HCV-infected patients undergoing antiviral therapy.
Kit demonstrated the ability to reproducibly detect the presence of HCV at the level of 20 IU/ml.